Daily Chart: NASDAQ IPOs forge ahead

Apart from a transient slowdown, the biotech IPO market on NASDAQ has barely registered a pandemic is happening.

Companies raised a combined $1.8 billion through the end of April, surpassing the same period last year, and extending a trend of increasing money raised to a fourth consecutive year...